ミネソタ州における大腸癌の臨床試験
ミネソタ州内の拠点で、大腸癌に関する45件の研究が参加者を募集しています。
ミネソタ州内の都市
- Rochester29件の研究
- Minneapolis19件の研究
- Saint Paul9件の研究
- Plymouth9件の研究
- Bloomington7件の研究
- Brooklyn Park7件の研究
- Duluth5件の研究
公式研究テキスト（英語）
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Sanford Joe Lueken Cancer Center, Bemidji
- Regions Hospital, Saint Paul
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05673148Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Riverwood Healthcare Center, Aitkin
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Essentia Health - Baxter Clinic, Baxter
- 他48件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Family Communications After Genetic Testing
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Essentia Health Saint Joseph's Medical Center, Brainerd
- 他41件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #68, Rochester
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483PRE-ISPY Phase I/II Oncology Platform Program
- University of Minnesota Masonic Cancer Center, Minneapolis
- Mayo Clinic Comprehensive Cancer Center, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT05868226Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Avera Cancer Institute- Marshall, Marshall
- Mayo Clinic Hospital, Methodist Campus, Research Pharmacy, Rochester
- Mayo Clinic Pharmacy, Rochester
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Mayo Clinic Rochester, Rochester
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT04981119Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT05863195A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Minnesota Oncology, Maple Grove
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07221357Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Mayo Clinic, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Mayo Clinic - Rochester, Rochester
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Masonic Cancer Center University of Minnesota, Minneapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT05786924An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
- Mayo Clinic in Rochester, Rochester
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06557733A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- Mayo Clinic Rochester, Rochester
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/11更新 · NCT04929223A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Minnesota Oncology Hematology, P.A., Saint Louis Park
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07549412Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Clinical Study Site, Saint Louis Park
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07228832FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- University of Minnesota Masonic Cancer Center, Minneapolis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/02更新 · NCT07216105The Vanguard Study: Testing a New Way to Screen for Cancer
- Minneapolis VA Medical Center, Minneapolis
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- University of Minnesota/Masonic Cancer Center, Minneapolis
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
- Research Site, Rochester
被験者募集中第2相
18歳〜130歳 · 全性別 · 2026/08/18更新 · NCT06792695Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
- Mayo Clinic, Rochester
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/18更新 · NCT05410977FOG-001 in Locally Advanced or Metastatic Solid Tumors
- M Health Fairview University of Minnesota Medical Center, Minneapolis
- Mayo Clinic, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05919264A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- M Health Fairview University of Minnesota Medical Center, Minneapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/05更新 · NCT06330064Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Health Partners Cancer Center at Regions Hospital, Saint Paul
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/03更新 · NCT07397338A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Minnesota Oncology Hematology, Maple Grove
- Mayo Clinic (Minnesota), Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Mayo Clinic Rochester, Rochester
被験者募集中第1相
18歳〜100歳 · 全性別 · 2026/07/29更新 · NCT06562192A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
- Minnesota Oncology Hematology, PA, Burnsville
- Allina Health Cancer institute, Coon Rapids
- Minnesota Oncology Hematology, PA, Coon Rapids
- 他17件
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/22更新 · NCT05253651A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Mayo Clinic Cancer Center, Rochester
- Mayo Clinic, Rochester
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT06131840A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
- May Clinic Rochester, Rochester
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/16更新 · NCT06948448A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Scri Minnesota Oncology Hematology, P.A. /ID# 275149, Minneapolis
- Mayo Clinic-Rochester /ID# 273508, Rochester
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/10更新 · NCT07023289Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Mayo Clinic in Rochester, Minnesota, Rochester
被験者募集中第1/2相
18歳〜90歳 · 全性別 · 2026/07/06更新 · NCT06710756A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Mayo Clinic Rochester, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06051695A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Minnesota Oncology Hematology - Primary, Maple Grove
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT07011576KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Mayo Clinic Comprehensive Cancer Center, Rochester
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/08更新 · NCT06026410A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- Mayo Clinic, Rochester, Rochester
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/23更新 · NCT06720987Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Essentia Health Saint Joseph's Medical Center, Brainerd
- 他38件
被験者募集中第3相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/03/31更新 · NCT07018869A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Mayo Clinic, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/27更新 · NCT06395519Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Essentia Health Saint Joseph's Medical Center, Brainerd
- Minnesota Oncology - Burnsville, Burnsville
- 他31件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Mayo Clinic in Rochester, Rochester
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/12更新 · NCT06349642cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Allina Health Cancer Institute, Minneapolis
- Mayo Clinic, Rochester
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。